Literature DB >> 26260307

Inflammation and plaque vulnerability.

G K Hansson1, P Libby2, I Tabas3.   

Abstract

Atherosclerosis is a maladaptive, nonresolving chronic inflammatory disease that occurs at sites of blood flow disturbance. The disease usually remains silent until a breakdown of integrity at the arterial surface triggers the formation of a thrombus. By occluding the lumen, the thrombus or emboli detaching from it elicits ischaemic symptoms that may be life-threatening. Two types of surface damage can cause atherothrombosis: plaque rupture and endothelial erosion. Plaque rupture is thought to be caused by loss of mechanical stability, often due to reduced tensile strength of the collagen cap surrounding the plaque. Therefore, plaques with reduced collagen content are thought to be more vulnerable than those with a thick collagen cap. Endothelial erosion, on the other hand, may occur after injurious insults to the endothelium instigated by metabolic disturbance or immune insults. This review discusses the molecular mechanisms involved in plaque vulnerability and the development of atherothrombosis.
© 2015 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  atherosclerosis; atherothrombosis; en-dothelial erosion; inflammation; plaque rupture

Mesh:

Substances:

Year:  2015        PMID: 26260307      PMCID: PMC5082111          DOI: 10.1111/joim.12406

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  95 in total

1.  Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.

Authors:  Yury I Miller; Suganya Viriyakosol; Dorothy S Worrall; Agnès Boullier; Susan Butler; Joseph L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-17       Impact factor: 8.311

2.  Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.

Authors:  Magnus Bäck; De-xiu Bu; Robert Bränström; Yuri Sheikine; Zhong-Qun Yan; Göran K Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

3.  Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease.

Authors:  Erik Ingelsson; Li Yin; Magnus Bäck
Journal:  J Allergy Clin Immunol       Date:  2012-01-12       Impact factor: 10.793

Review 4.  Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency.

Authors:  Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-09-01       Impact factor: 8.311

5.  Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis.

Authors:  Dorien M Schrijvers; Guido R Y De Meyer; Mark M Kockx; Arnold G Herman; Wim Martinet
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-14       Impact factor: 8.311

Review 6.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.

Authors:  A Farb; A P Burke; A L Tang; T Y Liang; P Mannan; J Smialek; R Virmani
Journal:  Circulation       Date:  1996-04-01       Impact factor: 29.690

7.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

8.  Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.

Authors:  P K Shah; E Falk; J J Badimon; A Fernandez-Ortiz; A Mailhac; G Villareal-Levy; J T Fallon; J Regnstrom; V Fuster
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

9.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme.

Authors:  Y J Geng; P Libby
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

Review 10.  Role of basic science in the development of new medicines: examples from the eicosanoid field.

Authors:  Bengt Samuelsson
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

View more
  218 in total

Review 1.  Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.

Authors:  Mark G MacAskill; David E Newby; Adriana A S Tavares
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

Review 2.  Inflammation, immune activation, and cardiovascular disease in HIV.

Authors:  Eric Nou; Janet Lo; Steven K Grinspoon
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

Review 3.  Implications for MicroRNA involvement in the prognosis and treatment of atherosclerosis.

Authors:  Samira Tabaei; Seyyedeh Samaneh Tabaee
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

Review 4.  Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2).

Authors:  Kathryn J Moore; Simon Koplev; Edward A Fisher; Ira Tabas; Johan L M Björkegren; Amanda C Doran; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

Review 5.  Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.

Authors:  Peter Libby; Joseph Loscalzo; Paul M Ridker; Michael E Farkouh; Priscilla Y Hsue; Valentin Fuster; Ahmed A Hasan; Salomon Amar
Journal:  J Am Coll Cardiol       Date:  2018-10-23       Impact factor: 24.094

6.  Sulindac-derived retinoid X receptor-α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE-/- mice.

Authors:  Linghong Shen; Zhe Sun; Peng Nie; Ruosen Yuan; Zhaohua Cai; Caizhe Wu; Liuhua Hu; Shuxuan Jin; Hu Zhou; Xiaokun Zhang; Ben He
Journal:  Br J Pharmacol       Date:  2019-05-23       Impact factor: 8.739

7.  Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by 18F-sodium fluoride PET/CT.

Authors:  Yoshinobu Ishiwata; Tomohiro Kaneta; Shintaro Nawata; Ayako Hino-Shishikura; Keisuke Yoshida; Tomio Inoue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-27       Impact factor: 9.236

Review 8.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

Review 9.  Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.

Authors:  James A Hamilton; Hatice Hasturk; Alpdogan Kantarci; Charles N Serhan; Thomas Van Dyke
Journal:  Curr Atheroscler Rep       Date:  2017-11-06       Impact factor: 5.113

10.  Bilateral symmetry of human carotid artery atherosclerosis: a multi-contrast weighted MR study.

Authors:  Feiyu Li; Xiaoying Wang
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.